2 studies found for:    16364519 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal Carcinoma
Condition: Metastatic Nasopharyngeal
Intervention: Drug: Interleukin, NK cells
2 Recruiting Natural Killer Cells and Bortezomib to Treat Cancer
Conditions: Lung or Prostatic Neoplasms;   Colorectal or Kidney Neoplasms;   Pancreatic Neoplasms;   Leukemia, Myelogenous, Chronic Lymphocytic Leukemia, BCR-ABL Positive;   Melanoma;   CLL
Intervention: Drug: NK cells +CliniMACs CD3 and CD56 systems

Indicates status has not been verified in more than two years